Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ≥ 18 years old, diagnosed with end-stage kidney disease~* Undergoing thrice-weekly chronic hemodialysis for more than 90 days~* Exhibit a WI-NRS score of 3 or higher~Exclusion Criteria:~* Ahistory of hemp allergy~* Pregnancy or breastfeeding~* Dermatologic diseases~* Adjustments to medications for controlling itch within the 14 days preceding the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- hemp group (Type: EXPERIMENTAL): They was assigned to apply the hemp-containing cream.
- Control group (Type: PLACEBO_COMPARATOR): They was assigned to apply the placebo cream.

Based on this trial design, predict the completion outcome and termination type (if applicable).